Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 930.00
-56.00 (-5.68%)
Oct 12, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 65.52 billion as of October 12, 2026. It is the 30,551st most valuable company in the world and the 1,647th biggest in South Korea. Its market cap has decreased by 68.67% in one year.
Market Cap
65.52B
Enterprise Value
117.66B
Revenue
46.69B
Global Rank
Country Rank
#1,647 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 65.52B, a decrease of -72.38%. That is a compound annual growth rate of -9.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 65.52B | -33.78% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoImmuneTech | 187.06B |
| Anterogen.Co.,Ltd. | 162.00B |
| Genexine | 132.12B |
| MedPacto | 102.31B |
| Vaxcell-Bio Therapeutics | 101.05B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 71.63B |
| ENCell | 64.74B |